FELDMAN; Marc

Patent Applications and Registrations

Patent applications and USPTO patent grants for FELDMAN; Marc.The latest application filed is for "method of treating early stage dupuytren's disease".

Company Profile

1.8.9

FELDMAN; Marc - London GB
Feldman; Marc - Woodland Hills CA US
Feldman; Marc - San Antonio TX
Feldman; Marc - Beachwood OH
Feldman; Marc - Highgate GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method Of Treating Early Stage Dupuytren's Disease App 20210040196 - NANCHAHAL; Jagdeep ; et al.	2021-02-11
Authentication of transactions in a network Grant 10,535,044 - Feldman Ja	2020-01-14
Apparatus and methods for optical coherence tomography and two-photon luminescence imaging Grant 10,495,440 - Feldman , et al. De	2019-12-03
Apparatus And Methods For Optical Coherence Tomography And Two-photon Luminescence Imaging App 20170122720 - FELDMAN; Marc ; et al.	2017-05-04
Methods App 20160333088 - Maze; Mervyn ; et al.	2016-11-17
Apparatus and methods for optical coherence tomography and two-photon luminescence imaging Grant 9,482,513 - Feldman , et al. November 1, 2	2016-11-01
Method for treatment of post operative cognitive dysfunction Grant 9,308,254 - Maze , et al. April 12, 2	2016-04-12
Apparatus And Methods For Optical Coherence Tomography And Two-photon Luminescence Imaging App 20140268168 - FELDMAN; Marc ; et al.	2014-09-18
Methods App 20130084299 - Maze; Mervyn ; et al.	2013-04-04
Authentication Of Transactions In A Network App 20110173124 - Feldman; Marc	2011-07-14
Computer-cost Subsidizing Method App 20100058378 - Feldman; Marc	2010-03-04
Drug Delivery From Implants Using Self-assembled Monolayers-therapeutic Sams App 20090123516 - Agrawal; C. Mauli ; et al.	2009-05-14
Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease Grant 6,270,766 - Feldman , et al. August 7, 2	2001-08-07
Treatment of rheumatoid arthritis with anti-CD4 antibodies in conjunction with anti-TNF antibodies Grant 5,741,488 - Feldman , et al. April 21, 1	1998-04-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.